Christopher Campbell > DLA Piper LLP (US) > Atlanta, United States > Lawyer Profile

DLA Piper LLP (US)
ATLANTA, GA 30309-3450
United States

Work Department

Litigation, Arbitration and Investigations; International Trade, Regulatory and Government Affairs; Product Liability, Mass Torts and Product Stewardship; Life Sciences; Healthcare


Partner; Chair, Product Liability and Mass Torts Practice; Chair, Atlanta Office D&I Committee


Chris Campbell is the Chair of DLA Piper’s Product Liability and Mass Tort practice group, which is among the world’s largest and most award-winning team of product liability defense counsel.

A graduate of Harvard Law School, Chris has 20 years’ experience in all phases of mass tort, class action, and other complex commercial litigation, including trying cases and arguing appeals. He has served as global, national, and trial counsel for many global companies in the life sciences, food and beverage, automotive, and insurance sectors. In addition, Chris also advises clients on regulatory, communications, and other strategic matters with the potential to impact the clients’ business interests or reputations.


Defense Research Institute; Lawyers for Civil Justice; U.S. Chamber of Commerce


J.D., Harvard Law School; B.S., Austin Peay State University

Lawyer Rankings

United States > Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)

Led from Atlanta by Christopher Campbell  and also aided by the firm’s broader nationwide commercial litigation offering, DLA Piper LLP (US)‘s product liability and mass torts practice is praised for its ‘creative thinking and dedication’ and its capacity to handle significant litigation, including class actions, across a myriad consumer products. Atlanta-based associate Emily Marshall continues to flourish in the product liability arena and is noted for her ability ‘to quickly grasp the technical aspects and translate that into the proper defensive stance’. 

United States > Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport

Benefiting from a sizeable overarching product liability and mass tort offering throughout the country and also aided by a raft of legal technology products including an expert witness portal and litigation analytics tool, DLA Piper LLP (US) is able to represent numerous transport-based clients in resource-intensive mandates. Philadelphia-based Matthew Goldberg represents a variety of multinational automotive and automobile component part manufacturers in complex litigation; including successfully helping Porsche Cars North America to resist numerous putative class actions relating to product liability, including defective engine and suspension systems. Although automotive clients remain central to the practice, it has also been fairly active in the aviation space, including work for several airlines defending against putative class actions seeking damages for an alleged failure to pay refunds due to Covid-19.  Christopher Campbell in Atlanta co-heads the team with Loren Brown in New York and James Brogan in Philadelphia. Baltimore-based Joel Dewey has vast experience at trial and appellate level, including in the context of class actions and MDL proceedings for automotive manufacturers.

United States > Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices

The ‘extremely responsive and thoughtful’ team at DLA Piper LLP (US) provides an ‘excellent client service and medical device knowledge’ to a wide range of pharmaceuticals companies, including Sanofi and Bayer, across a range of major product liability mandates. While the firm has a growing profile in trying cases, it is particularly adept at achieving an early conclusion of cases, through its effective use of dispositive pre-emption motions and Daubert challenges. Loren Brown in New York regularly acts as national co-ordinating counsel and lead trial counsel in mass torts and MDLs throughout the country, as well as in the context of global litigation – including her work for Bayer in mass tort litigation involving Essure. Based out of Atlanta, product liability chair Christopher Campbell is noted for his high-level strategic advice to manufacturers across a range of products, including many within the pharmaceutical space, where he is appreciated for his ‘guidance on the big picture’, as well his aptitude at handling cross-border mandates. Boston-based global co-chair of the firm’s life sciences sector, Matthew Holian is ‘super smart and very strategic‘ throughout the product life cycle, from risk assessment, pre-litigation discovery, bellwether trials and, ultimately, resolution. ‘Highly-skilled‘ Boston-based Katie Insogna excels at handling high-stakes litigation and counselling. Based out New York, Lucas Przymusinski provides ‘thoughtful guidance‘ to pharma companies across an array of regulatory and litigation matters, including product liability disputes, where his medical and science background provides additional benefit.